Rather than as an experimental validation of this particular link bettwen loss-of-function mutations of MLL2 and the miss-regulation of the MTOR module –which, outside the scope of our study, must be undertaken by the cancer research community– this result lends support to the validity of our approach. The gene discussed is MTOR; the disease is cancer.